Sonoma Pharmaceuticals Presents Business and Financial Update

TipRanksApr 9 07:42 ET

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid

AccesswireApr 9 07:30 ET

Express News | Sonoma Reports Recent Publication From Australia Highlighting Potential For Microdox In Managing Urinary Tract Infections

Moomoo 24/7Apr 4 07:36 ET

Express News | Sonoma Pharmaceuticals Reported A Recent Publication In The Journal Neurourology And Urodynamics Highlighting The Potential For Microdox In The Management Of Urinary Tract Infections In Children With Neurogenic Or Non‐Neurogenic Bladder Dysfunction

Moomoo 24/7Apr 4 07:36 ET

Sonoma Pharmaceuticals Reports Recent Publication From Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous ac

AccesswireApr 4 07:30 ET

Sonoma Pharmaceuticals Outlines Growth and Challenges

TipRanksApr 2 07:42 ET